Zoetis Aktie 2026 // Gewinn wächst, Aktie fällt – ist das die Chance?

Zoetis is one of the world's leading companies in the field of animal health. However, its stock has been under pressure for years. While revenue and profit continue to grow in the long term, the market has significantly punished the stock. Is this a rare entry opportunity in a quality company, or is there more to the price decline than just overreaction? This Zoetis stock analysis for 2026 examines current business performance, the slowing growth momentum, stable margins, share buybacks, dividends, valuation, and the technical chart pattern. The contrast is particularly striking: the company remains profitable, and the industry offers long-term growth potential. Yet the share price continues to show weakness. The risks are also assessed in detail: declining veterinary visits following the pandemic boom, problems in the dermatology sector, disappointing quarterly results, and the question of whether the low valuation is truly attractive or a warning sign. Table of Contents 00:00 Intro 00:55 Long-Term Chart: Zoetis 02:24 Zoetis vs. S&P 500 vs. S&P 500 Healthcare ETF (XLV) vs. ProShares Pet Care ETF (PAWZ) 03:05 Zoetis vs. IDEXX Laboratories vs. Virbac vs. Merck & Company vs. Elanco vs. Neogen 03:53 Zoetis Business Units 05:05 Fewer Pet Visits 06:36 Product Issues 07:11 Animal Health Market Outlook 07:53 Zoetis's Competitive Moat 09:11 Ownership 10:00 Revenue & Margins vs. Video from 2025 10:53 Zoetis's Annual Revenue Growth 11:27 Revenue by Segment & Region 12:04 Profit, Cash Flows & Dividends vs. Video from 2025 12:34 Balance Sheet Overview & Share Buybacks 13:24 Key Figures (P/E Ratio) vs. Competitors 14:05 Dividend Yield 14:35 Valuation: Zoetis vs. Video from 2025 15:28 Chart Analysis: Zoetis vs. Video from 2025 16:34 Is Zoetis Stock Currently a Buy? 17:55 Disclaimer & Thanks for Tuning In! 🧭 Stock Market Compass https://www.boersen-kompass.de Social Media Instagram:   / maximilian_gamperling   LinkedIn:   / gamperling   Newsletter: https://www.maximilian-gamperling.de/... Podcast: https://akademie.maximilian-gamperlin... My Tools Charts*: https://de.tradingview.com/?aff_id=11... Stock Finder: https://aktienfinder.net Fiscal.ai*: https://fiscal.ai/?via=maximilian TransparentShare: https://bit.ly/3laA6tK SeekingAlpha*: https://www.sahg6dtr.com/QHJ7RM/R74QP/ Captrader*: https://www.financeads.net/tc.php?t=4... Disclaimer All information is based on sources we consider reliable. Despite careful processing, we cannot guarantee the accuracy of the information and prices. All opinions and information contained herein are for informational purposes only and do not constitute any liability. Recourse claims, both direct and indirect, and warranties are therefore excluded. All opinions and information contained herein should not be construed as an invitation to enter into any business or transaction. Furthermore, the strategies presented do not constitute a recommendation to replicate them, either explicitly or implicitly. Before entering into any business or transaction, you should assess whether it is suitable for your personal and financial circumstances. We expressly point out once again that trading in stocks, ETFs, funds, options, futures, etc., involves inherent risks, and the total loss of invested capital cannot be ruled out. Statements about expected developments in financial markets, particularly securities markets and commodity futures exchanges, NEVER constitute a solicitation to buy or sell financial instruments, but serve only for general information purposes. This applies even if, upon literal interpretation, posts could be understood as a solicitation to carry out transactions as described above. Any liability in this regard is excluded. *Affiliate Link #Zoetis #StockMarket #Stocks